Immuron Limited is commercializing and developing a novel class of specifically targeted polyclonal antibodies which are delivered within the gastrointestinal tract and do not cross into the bloodstream. Products in clinical development have the potential to transform standard of care for moderate to severe Campylobacteriosis, Clostridioides difficile infections, Enterotoxigenic Escherichia coli (ETEC) infections and Traveler¿s Diarrhea. Immuron markets Travelan® in Australia, Canada and the U.S. In Australia, Travelan® is indicated to reduce the risk of travelers' diarrhea and to reduce the risk of minor gastro-intestinal disorders. In Canada, Travelan® is indicated to reduce the risk of travelers' diarrhea. In the U.S, Travelan® is a dietary supplement for digestive tract protection.
Quote | Immuron Limited (NASDAQ:IMRN)
Last: | $2.52 |
---|---|
Change Percent: | 5.44% |
Open: | $2.4885 |
Close: | $2.39 |
High: | $2.57 |
Low: | $2.45 |
Volume: | 4,188 |
Last Trade Date Time: | 07/30/2024 03:00:00 am |
News | Immuron Limited (NASDAQ:IMRN)
Sales Highlights: MELBOURNE, Australia, July 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce record sales (unaudited) of Travelan ® , an over-the-counter immune ...
2024-07-03 07:54:15 ET More on Immuron Immuron gains after Travelan sales update Financial information for Immuron Read the full article on Seeking Alpha For further details see: Immuron to raise up to $2M as part of an ATM equity offering
Message Board Posts | Immuron Limited (NASDAQ:IMRN)
Subject | By | Source | When |
---|---|---|---|
$IMRN good News Out running hard | knrorrel | investorshub | 05/08/2023 1:59:23 PM |
Finally something going up.. $IMRN$... | Pisd | investorshub | 05/08/2023 12:04:27 PM |
That's great news! Thanks. | subslover | investorshub | 05/08/2023 11:01:43 AM |
Immuron Announces FDA Removed Clinical Hold on New | tw0122 | investorshub | 05/08/2023 10:53:12 AM |
what do you make of this data? | THEMASTERS_SON | investorshub | 05/06/2023 11:32:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Sales Highlights: MELBOURNE, Australia, July 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce record sales (unaudited) of Travelan ® , an over-the-counter immune ...
MELBOURNE, Australia, July 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce that it has filed a pre-IND (investigational new drug) application with the United States Food and Drug A...
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as Non-Executive Director effective today. Roger was appointed a...